• 14 - HCT Across MDS Genetic Subtypes, Part II: The Role of Genetics and Early Consult

  • Jan 14 2025
  • Duración: 32 m
  • Podcast

14 - HCT Across MDS Genetic Subtypes, Part II: The Role of Genetics and Early Consult

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this two-part "Explore Cell Therapy" podcast episode, Coleman Lindsley, MD, PhD, and Corey Cutler, MD, MPH, FRCP(C), discuss recent and evolving research supporting the broad benefits of hematopoietic cell transplant (HCT) across all genetic subtypes of myelodysplastic syndrome (MDS), including for patients with high-risk mutations like TP53.

    In Part II, experts stress the importance of early consultation to optimize treatment decisions and ensure equity in access to HCT for older patients in need of a curative treatment option.

    To read bios on the panelists and to access additional resources related to this episode, visit Our Site.

    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre 14 - HCT Across MDS Genetic Subtypes, Part II: The Role of Genetics and Early Consult

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles